Marijuana Stocks 2

[$Pistol Pete$]

$PMCB 10 healthcare innovations that will change the world





CELL-IN-A-BOX
One of the key challenges of live cell implantation is the body’s rejection of anything that “looks” foreign to the immune system. All too often a donated organ or tissue is attacked by the recipient immune system, causing a myriad of problems.

What if, however, those living cells could be encapsulated by a durable shell, allowing the cells inside to operate as usual, but protecting them from an attack by white blood cells?
That’s exactly what Cell-in-a-Box from Pharmacyte Biotech (PMCB) does. That is, it envelopes a certain kind of cell in a strong but partially porous shell, allowing them to produce a variety of necessary enzymes, hormones, etc., but without inducing the tissue scarring that’s been witnessed with other encapsulation attempts.

One capsule, about the size of the head of a pin, can hold thousands of cells.
To date, the Cell-in-a-Box platform has been used to activate cancer drugs very near the point of the tumor in pancreatic cancer patients, but the most exciting prospect of the biotechnology so far is the encapsulation of insulin-producing cells. That’s right — Cell-in-a-Box may be a way of creating an artificial pancreas for diabetics.

Pharmacyte Biotech is an OTC stock, and a penny stock to boot, so use an appropriate amount of caution. But, that doesn’t make the biotechnology any less cool.